Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight
额颞叶痴呆及相关疾病:转录组分析、生物标志物发现和机制洞察
基本信息
- 批准号:10597677
- 负责人:
- 金额:$ 78.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-15 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:ALS patientsAccelerationAlternative SplicingAmyotrophic Lateral SclerosisAutopsyBinding ProteinsBiological MarkersBloodBlood specimenBrainC-terminalC9ORF72Candidate Disease GeneCell Culture TechniquesCell NucleusCell modelCerebellumClinicalClinical TrialsCollectionComplementComplexCultured CellsCytoplasmic ProteinDataDefectDiagnosisDiseaseEventExhibitsFrontotemporal DementiaFrontotemporal Lobar DegenerationsFutureGenesGeneticGenetic TranscriptionIndividualInvestigationLengthMeasurableMessenger RNAMethodsModelingMolecularMolecular ProfilingMutationNeuroanatomyNeurodegenerative DisordersPathogenesisPathologicPathologyPathway interactionsPatientsPhosphorylationPlayPoly(A) TailPoly(A)-Binding ProteinsPreparationPrognostic MarkerPropertyProteinsRNARNA ProcessingRNA SplicingRNA-Binding ProteinsRecoveryRoleSpecimenStressSystemTechniquesTechnologyTestingTherapeutic InterventionTimeTissuesTranscriptTransportationVariantbiomarker discoverybrain tissuecandidate markercausal variantcell typecohortdiagnostic biomarkerdruggable targetfrontal lobefrontotemporal lobar dementia amyotrophic lateral sclerosisin vivoinnovationinsightmRNA StabilitymRNA Translationneuropathologynew therapeutic targetnovelnovel markerpharmacodynamic biomarkerpotential biomarkerprofiles in patientsprotein TDP-43protein functionsample collectionsingle nucleus RNA-sequencingstathmintargeted treatmenttranscriptometranscriptome sequencingtranscriptomic profilingtranscriptomicsvariant detection
项目摘要
PROJECT SUMMARY/ABSTRACT
We seek to discover novel biomarkers and drug targets for frontotemporal dementia (FTD) and related
disorders. FTD is a fatal neurodegenerative disorder that demonstrates substantial clinical, genetic, and
pathological overlap with amyotrophic lateral sclerosis (ALS). Although both diseases can display TAR DNA-
binding protein 43 (TDP-43) pathology, much remains unknown about the underlying mechanisms. It has been
suggested that RNA processing pathways play a vital role, which is exemplified by the description of mutations
in genes encoding RNA-binding proteins and the abundance of splicing defects in TDP-43 proteinopathies.
Given the fact that long-read sequencing techniques have a higher accuracy in splice junctions, a better
recovery of large transcripts, and detect more alternative splicing events than traditional sequencing methods
that rely on short reads, we will produce full-length long-read transcriptomic data. We will examine a well-
characterized pathological cohort of patients belonging to the FTD-ALS spectrum for whom frontal cortex and
cerebellar tissue are available. Additionally, we will create single-nuclei long-read sequencing data, enabling us
to determine in which cell type specific transcript variants are detected. This innovative approach will allow us
to capture transcriptomic diversity, aiding the identification of novel, disease-specific, and/or disease-relevant
transcript variants (Aim 1). We will compare the RNA signature observed in the brain to that seen in a large
collection of clinical blood specimens. Moreover, we will assess differences between presymptomatic and
symptomatic individuals and evaluate changes over time. These studies give us the ability to reveal interesting
biomarker candidates, which will be validated in our extensive biospecimen collection (Aim 2). To elucidate the
mechanisms underpinning these diseases, we will also perform in-depth mechanistic studies using various cell
culture models, in vivo systems, and post-mortem tissues from patients along the FTD-ALS spectrum (Aim 3).
Our original strategy, thorough characterization, and precious sample collection, will accelerate the
discovery of pathological mechanisms, druggable targets and translatable biomarkers, which are highly
valuable in preparation of future clinical trials for FTD and related disorders.
项目总结/摘要
我们寻求发现额颞叶痴呆(FTD)及相关疾病的新生物标志物和药物靶点。
紊乱FTD是一种致死性神经退行性疾病,在临床、遗传和免疫学方面表现出显著的
与肌萎缩侧索硬化症(ALS)的病理重叠。虽然这两种疾病都可以显示TAR DNA-
结合蛋白43(TDP-43)的病理学,许多仍然未知的潜在机制。已经
表明RNA加工途径起着至关重要的作用,这一点可以通过对突变的描述来说明。
在编码RNA结合蛋白的基因和TDP-43蛋白病中剪接缺陷的丰度。
考虑到长读段测序技术在剪接点中具有更高的准确性,
回收大转录本,并检测比传统测序方法更多的选择性剪接事件
我们将产生全长的长读段转录组数据。我们会检查一个井-
属于FTD-ALS谱的患者的特征性病理队列,
小脑组织是可用的。此外,我们将创建单核长读序测序数据,使我们能够
以确定在哪些细胞类型特异性转录物变体中被检测到。这种创新的方法将使我们
捕获转录组多样性,帮助鉴定新的、疾病特异性的和/或疾病相关的
转录变体(目标1)。我们将比较在大脑中观察到的RNA特征和在大的
采集临床血液标本。此外,我们将评估症状前和症状后的差异。
症状个体并评估随时间的变化。这些研究使我们能够揭示有趣的信息
候选生物标志物,这将在我们广泛的生物标本收集中得到验证(目标2)。阐明本
为了了解这些疾病的发病机制,我们还将使用各种细胞因子进行深入的机制研究。
培养模型、体内系统和沿着FTD-ALS谱的患者死后组织(目标3)。
我们独创的策略、彻底的表征和珍贵的样品收集,将加速
发现病理机制,可药用靶标和可翻译的生物标志物,这是高度
对准备未来FTD和相关疾病的临床试验有价值。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Advances in sequencing technologies for amyotrophic lateral sclerosis research.
- DOI:10.1186/s13024-022-00593-1
- 发表时间:2023-01-13
- 期刊:
- 影响因子:15.1
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tania France Gendron其他文献
Tania France Gendron的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tania France Gendron', 18)}}的其他基金
Poly(ADP-ribose) promotes the condensation and toxicity of C9orf72 arginine-rich dipeptide repeat proteins
聚(ADP-核糖)促进 C9orf72 富含精氨酸的二肽重复蛋白的缩合和毒性
- 批准号:
10707931 - 财政年份:2021
- 资助金额:
$ 78.09万 - 项目类别:
Poly(ADP-ribose) promotes the condensation and toxicity of C9orf72 arginine-rich dipeptide repeat proteins
聚(ADP-核糖)促进 C9orf72 富含精氨酸的二肽重复蛋白的缩合和毒性
- 批准号:
10298581 - 财政年份:2021
- 资助金额:
$ 78.09万 - 项目类别:
Poly(ADP-ribose) promotes the condensation and toxicity of C9orf72 arginine-rich dipeptide repeat proteins
聚(ADP-核糖)促进 C9orf72 富含精氨酸的二肽重复蛋白的缩合和毒性
- 批准号:
10448297 - 财政年份:2021
- 资助金额:
$ 78.09万 - 项目类别:
Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight
额颞叶痴呆及相关疾病:转录组分析、生物标志物发现和机制洞察
- 批准号:
10180652 - 财政年份:2021
- 资助金额:
$ 78.09万 - 项目类别:
Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight
额颞叶痴呆及相关疾病:转录组分析、生物标志物发现和机制洞察
- 批准号:
10392505 - 财政年份:2021
- 资助金额:
$ 78.09万 - 项目类别:
Pathologically modified TDP-43 in neurodegenerative diseases
病理修饰的 TDP-43 在神经退行性疾病中的应用
- 批准号:
8263381 - 财政年份:2011
- 资助金额:
$ 78.09万 - 项目类别:
Pathologically modified TDP-43 in neurodegenerative diseases
病理修饰的 TDP-43 在神经退行性疾病中的应用
- 批准号:
8093934 - 财政年份:2011
- 资助金额:
$ 78.09万 - 项目类别:
相似海外基金
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 78.09万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 78.09万 - 项目类别:
Continuing Grant
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 78.09万 - 项目类别:
Research Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 78.09万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 78.09万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 78.09万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 78.09万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 78.09万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 78.09万 - 项目类别:
Standard Grant
Radiation GRMHD with Non-Thermal Particle Acceleration: Next-Generation Models of Black Hole Accretion Flows and Jets
具有非热粒子加速的辐射 GRMHD:黑洞吸积流和喷流的下一代模型
- 批准号:
2307983 - 财政年份:2023
- 资助金额:
$ 78.09万 - 项目类别:
Standard Grant